Investing Profile

Alaa Halawa(1)

InvestorVC
Head of Healthcare at Mubadala
mubadala.comLos Altos, California
Your Intro Paths to Alaa Halawa

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Alaa is a member of
NewCo Network
1586 CONNECTIONS
Self-Employed Network
425 CONNECTIONS
Cornell University Network
174 CONNECTIONS

Find Alaa Halawa on

cb
Current Investing Position
Mubadala
Investment Range
$10K - $5.0M
Sweet Spot
$100K
Investments On Record
19

Alaa Halawa is on these Sector & Stage Rankings

Alaa Halawa's Investments On Record (14)

CompanyStageDateRound SizeTotal Raised
Alloy Therapeutics
Series EApr 2026$40M
Series DOct 2022$42M
Series CApr 2021$75M
$160M
Co-investors: Paul Grossinger (Gaingels), Alex Kolicich (8VC), Peter Thiel (Founders Fund)
Salma Health
Series AFeb 2026$80M
$80M
Co-investors: Paul Berns (ARCH Venture Partners)
Paradigm
Series BDec 2025$78M
Series AJan 2023$200M
$320M
Co-investors: Hemant Taneja (General Catalyst), Elena Viboch (General Catalyst), David Schenkein (GV (Google Ventures)), Ramnik Arora (FTX Ventures), Max Rimpel (Index Ventures), Niko Bonatsos (General Catalyst), Bilal Zuberi (Lux Capital), Stephen Knight (F-Prime Capital Partners), Brett Cook (F-Prime Capital Partners), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Justin Kao (DFJ Growth), Jared Friedman (Israel Defense Forces), Scott Belsky (A24), Eoghan McCabe, Arash Ferdowsi, Karim Atiyeh, Balaji Srinivasan
Ollin Biosciences
Series ASep 2025$100M
$100M
Co-investors: Paul Berns (ARCH Venture Partners)
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Paul Berns (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners)
GC Therapeutics
Series ASep 2024$65M
$65M
Co-investors: Vineeta Agarwala (Andreessen Horowitz)
Centenara Labs
Series BSep 2023$75M
$75M
EpiBiologics
Series AMar 2023$73M
$200M
Co-investors: David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Samuel Bjork (Digitalis Ventures), Nisa Leung (Qiming Venture Partners), Laura Brass (MPM BioImpact), Gaurav Aggarwal (Vivo Capital)

Alaa Halawa's Experience

Board Member Neumora2021 - Present
Board Member xilis2021 - Present
Founding Investor and Board Member Pretzel Therapeutics2021 - Present
Board Member Alloy Therapeutics, Inc.2021 - Present
Board Observer EQRx2021 - Present
Board Observer Outpace Bio2021 - Present
Investor Science 372020 - Present
Investor Ciitizen2020 - Present
Investor Lyell Immunopharma2020 - Present
Board Member Wellpay2020 - Present
Board Member Innovaccer2019 - Present
Board Observer IonQ Inc.2019 - Present
Investor Vividion Therapeutics. Inc.2019 - Present
Board Observer Unlearn.AI2019 - Present
Investor Primer AI2018 - Present
Investor Orca Biosystems Inc.2018 - Present
Investor Vir Biotechnology, Inc.2018 - Present
Investor insitro2018 - Present
Board Observer Recursion Pharmaceuticals2017 - Present
Head of Healthcare Mubadala2017 - Present
Board Observer NewCoPresent
Executive Director / Head of US Ventures MubadalaPresent
Board Member XilisPresent
Board Member WellPayPresent
Board Observer Unlearn.aiPresent
Investor InsitroPresent
Investor Primer.aiPresent
Board Observer RecursionPresent
Board Observer Self-EmployedPresent
Board Observer IonQPresent
Investor Vividion Therapeutics, Inc.Present
Investor Orca BioPresent
Cofounder and Chief Executive Officer Salma HealthPresent
Founding Investor and Board Member Tenvie TherapeuticsPresent
Founding Investor and Board Member Ollin BiosciencesPresent
Founding Investor MetseraPresent
Vice President - Mubadala Technology MubadalaPresent
Director, Strategy & Corporate Development GLOBALFOUNDRIES2014 - 2015
Vice President - Mubadala Technology Mubadala Development Company2009 - 2014
Director of Marketing and Product Management Globitel2004 - 2009

Alaa Halawa's Education

Cornell University Master of Business Administration (MBA) Business Administration and Management, General
University of Jordan B.Sc. Electrical Engineering